Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04798248 · ClinicalTrials.gov registry record · NA
Evaluation of Momentary Affect Regulation - Safer Sex Intervention
A NA study, sponsored by The Policy & Research Group.
- Completed
- Registry status
- NA
- Development phase
- 405
- Enrollment target
NCT04798248: Completed NA study, sponsored by The Policy & Research Group.
NCT04798248 is a NA study that has completed, run by The Policy & Research Group. The registered enrollment target is 405 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04798248, a NA study, has completed, sponsored by The Policy & Research Group.
- COMPLETED
- Registry status
- NA
- Development phase
- 405 participants
- Enrollment target
Study Summary
The purpose of the study is to determine the impact of the offer to participate in the Momentary Affect Regulation - Safer Sex Intervention (treatment) relative to the offer to participate in the control condition on participants' reported condom use, use of effective contraception, and number of sexual partners three months after the end of the treatment intervention.
Primary Outcome
Participant self-report on the number of times having vaginal sex without using a condom during the past 30 days
Interventions
- BEHAVIORAL Momentary Affect Regulation - Safer Sex Intervention (MARSSI)
- BEHAVIORAL Podcast Health Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 405 participants |
| Start Date | 2021-06-19 |
| Est. Completion | 2024-06-30 |
| Phase | NA |
What the finished NCT04798248 record still lists
NCT04798248 is an interventional study that assigns participants to a tested intervention. The registered 405 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower).
The record links to 0 conditions, and to 2 interventions - of which Momentary Affect Regulation - Safer Sex Intervention (MARSSI) is the first listed.
NCT04798248 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04798248 about?
NCT04798248 is a clinical study titled "Evaluation of Momentary Affect Regulation - Safer Sex Intervention". The purpose of the study is to determine the impact of the offer to participate in the Momentary Affect Regulation - Safer Sex Intervention (treatment) relative to the offer to participate in the control condition on participants' reported condom use, use of effective contraception, and number of se...
What is the current status of trial NCT04798248?
This trial is currently completed. It is a NA study. The enrollment target is 405 participants. The study started on 2021-06-19. Estimated completion is 2024-06-30.
What interventions are being tested in trial NCT04798248?
The interventions under investigation include: Momentary Affect Regulation - Safer Sex Intervention (MARSSI) (BEHAVIORAL), Podcast Health Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT04798248?
This trial is sponsored by The Policy & Research Group, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04798248's enrollment target sits among peer trials
405 243rd of 2000 higher than 1,757 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05576350 · 405 participants · NA
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
- NCT07066657 · 405 participants · Phase 1
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
- NCT06223360 · 406 participants · Phase 2
A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)
- NCT06411769 · 406 participants · NA
Evidence-based Intervention to Improve Walking Engagement in El Paso, Texas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI